“…The C. albicans was selected for association study, because, it is the most common pathogenic agent involved in systemic infections and the main strain responsible for infections caused by Candida fungi (Romani, 2012;Yapar, 2014). In previous studies, of our research group, with other species of this genus, P. brownianum and P. guajava extracts had their antifungal potential investigated, obtaining favorable results, where they also managed to affect the phenotypic plasticity of C. albicans and C. tropicalis, reducing the formation process of hyphae and pseudohyphae as their concentrations were increased (Morais- Braga et al, 2016bBraga et al, ,a, 2017. Candida albicans is a polymorphic fungus that can grow both in the yeast form (ovoid form), elongated ellipsoid cells with constrictions in the septa (pseudohyphae), or as true hyphae of parallel walls, as can be observed in Figure 2 -Growth Control (Berman, 2002).…”